CHEST  /  Industry Advisory Council

Industry Advisory Council

The IAC will:

  • Serve as a forum for the corporate community and CHEST to discuss key issues and their implications.
  • Provide a setting for discussions on technical and business trends that may influence CHEST and corporate strategic planning decisions.
  • Provide feedback to CHEST for corporate development and funding opportunities.

View the 2021 Industry Advisory Council (IAC) Benefits (PDF)


 CHEST Lung Cancer Summit Supplement (PDF)

The content in this supplement is based on proceedings from the Lung Cancer Summit, hosted by CHEST in July 2019. The summit successfully fostered key relationships between clinicians, educators, scientists, advocacy groups, payers, and government entities. Attendees identified opportunities to align efforts toward moving forward a research agenda, supporting the faster-paced adoption of key innovations in care, and improving the accessibility of those innovations to all patient populations. These papers highlight the key clinical elements of the summit. Dr. Silvestri served as Chair of the Summit Steering Committee.

For information on joining the Industry Advisory Council, contact:

Rachel Cahill
Market Growth Specialist
Office: +1 (224) 521-9515
rcahill@chestnet.org

2021 Industry Advisory Council Members

 


PLATINUM MEMBERSHIP


AMGEN Logo

Bayer logo

Genentech logo

MERCK Logo

Natera Logo

Sanofi Genzyme Regeneron logo



GOLD MEMBERSHIP


 

AstraZeneca

Boston Scientific

Janssen | Johnson & Johnson logo

Insmed Logo

Theravance Biopharma logo

Vapotherm logo

Vertex

Viatris logo

Advertisement